FURIC 40MG

About

Furic 40mg, containing Febuxostat, is a non-purine selective inhibitor of xanthine oxidase, an enzyme critical for the biosynthesis of uric acid. It is indicated for the chronic management of hyperuricemia in adult patients with gout, a metabolic disorder characterized by elevated levels of uric acid in the blood, leading to the formation of urate crystals in joints and soft tissues. By inhibiting xanthine oxidase, febuxostat effectively reduces the production of uric acid, thereby lowering serum uric acid concentrations. This action helps to prevent the recurrence of gout flares, dissolve existing urate crystals, and mitigate the long-term complications of gout, such as joint damage and kidney stones. Treatment should typically be initiated after an acute gout attack has subsided, as starting during a flare can transiently worsen symptoms. Regular monitoring of uric acid levels is essential to ensure therapeutic efficacy.

Uses

• Chronic management of hyperuricemia.
• Prevention of gout flares.
• Reduction of serum uric acid levels.
• Dissolution of urate crystals.

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your physician. Do not crush or chew the tablet.

Benefits

• Effectively lowers serum uric acid.
• Reduces the incidence of gout attacks.
• Helps prevent joint damage.
• Offers a convenient once-daily dose.
• Can be taken independently of meals.
• Provides long-term disease management.

Side Effects

• Nausea
• Diarrhea
• Headache
• Liver function abnormalities
• Rash
• Joint pain
• Dizziness
• Muscle pain
• Swelling
• Chest pain
• Palpitations
• Initial gout flares

Safety Measures

• Alcohol - Alcohol consumption, especially beer and spirits, can increase uric acid levels and may counteract the effects of febuxostat. It is advisable to limit or avoid alcohol.
• Pregnancy - Febuxostat is generally not recommended during pregnancy due to insufficient data on human fetal risk. Consult your doctor for alternatives.
• Breastfeeding - It is unknown if febuxostat is excreted in human milk. A decision should be made whether to discontinue nursing or the drug, considering the benefit to the mother.
• Liver - Use with caution in patients with mild to moderate hepatic impairment. Regular monitoring of liver function tests is recommended. Severe impairment is a contraindication.
• Kidney - Dose adjustment may be necessary in patients with severe renal impairment. Use with caution and monitor kidney function.
• Lung - No specific contraindications or dose adjustments are typically required for patients with lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.